Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
Y. Zeng, C. Hu, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Prolonged response to first-generation tyrosine kinase inhibitor in a metastatic non-small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review
K. H. Do, D. T. Le, et al.
Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non-small cell lung cancer: A multicenter Phase 2 clinical trial
T. Sonoda, Y. Umeda, et al.
The Long Run towards Personalized Therapy in Non-Small-Cell Lung Cancer: Current State and Future Directions
C. Genova
A comparative analysis of endometrial cancer disparities in incidence, mortality, and survival between women living in Puerto Rico, Non-Hispanic Blacks, Non-Hispanic Whites, and US Hispanics between 2000-2018
A. Rosario-santos, C. R. Torres-cintrón, et al.
